rs192017781
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020921.4(NIN):c.3647G>A(p.Arg1216Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000492 in 1,614,016 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_020921.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NIN | NM_020921.4 | c.3647G>A | p.Arg1216Gln | missense_variant | 18/31 | ENST00000530997.7 | NP_065972.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NIN | ENST00000530997.7 | c.3647G>A | p.Arg1216Gln | missense_variant | 18/31 | 5 | NM_020921.4 | ENSP00000436092.2 |
Frequencies
GnomAD3 genomes AF: 0.000322 AC: 49AN: 152158Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000334 AC: 84AN: 251128Hom.: 0 AF XY: 0.000354 AC XY: 48AN XY: 135746
GnomAD4 exome AF: 0.000510 AC: 745AN: 1461740Hom.: 0 Cov.: 64 AF XY: 0.000484 AC XY: 352AN XY: 727166
GnomAD4 genome AF: 0.000322 AC: 49AN: 152276Hom.: 0 Cov.: 31 AF XY: 0.000363 AC XY: 27AN XY: 74452
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2024 | The c.3647G>A (p.R1216Q) alteration is located in exon 18 (coding exon 16) of the NIN gene. This alteration results from a G to A substitution at nucleotide position 3647, causing the arginine (R) at amino acid position 1216 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jun 10, 2015 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1216 of the NIN protein (p.Arg1216Gln). This variant is present in population databases (rs192017781, gnomAD 0.05%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with NIN-related conditions. ClinVar contains an entry for this variant (Variation ID: 211610). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at